Literature DB >> 17873494

Influence of vigilance and learning on prefrontal activation in schizophrenia.

Christine Esslinger1, Harald Gruppe, Peter Danos, Stefanie Lis, Jochen Broll, Joerg Wiltink, Bernd Gallhofer, Peter Kirsch.   

Abstract

BACKGROUND: Executive functions, which are neuroanatomically associated with the frontal lobe, are known to be impaired in schizophrenia. It is, however, still unclear whether the underlying functional disturbance is due to a hyper- or a hypoactivation of the dorsolateral prefrontal cortex (DLPFC) or neither.
METHODS: To address this question, we examined the brain activation of 21 schizophrenic patients on atypical antipsychotic medication and 21 healthy control subjects during a mental maze task by means of fMRI.
RESULTS: We found no significant overall difference in cerebral activation between the groups, but differences in the change in DLPFC activation from the first to the second half of the experiment. In the maze compared to the control task, there was a decrease in activation in the DLPFC in the patients and an almost significant increase in the controls. The change in activation in the patient group correlated with a change in subjective sleepiness, while the increase in activation in the controls could be attributed to learning processes.
CONCLUSION: We hypothesized that differential temporal influences on brain activation could lead to either hyper- or hypoactivation of the DLPFC in schizophrenia. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873494     DOI: 10.1159/000108378

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  1 in total

1.  Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study.

Authors:  S G Potkin; J A Turner; G G Brown; G McCarthy; D N Greve; G H Glover; D S Manoach; A Belger; M Diaz; C G Wible; J M Ford; D H Mathalon; R Gollub; J Lauriello; D O'Leary; T G M van Erp; A W Toga; A Preda; K O Lim
Journal:  Schizophr Bull       Date:  2008-11-27       Impact factor: 9.306

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.